Position-specific N- and O-glycosylation of the reactive center loop impacts neutrophil elastase–mediated proteolysis of corticosteroid-binding globulin

Authors:

Anastasia Chernykh 1, Jodie L. Abrahams 1 2, Oliver C. Grant 3, Lucas Kambanis 4 5, Zeynep Sumer-Bayraktar 1 6, Julian Ugonotti 1, Rebeca Kawahara 1 7, Leo Corcilius 4 5, Richard J. Payne 4 5, Robert J. Woods 3, Morten Thaysen-Andersen 1 7

Affiliation:

School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia

Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan

Project Image

Description:

Corticosteroid-binding globulin (CBG) delivers anti-inflammatory cortisol to inflamed tissues through proteolysis of an exposed reactive center loop (RCL) by neutrophil elastase (NE). We previously demonstrated that RCL-localized Asn347-linked N-glycans impact NE proteolysis, but a comprehensive structure–function characterization of the RCL glycosylation is still required to better understand CBG glycobiology. Herein, we first performed RCL-centric glycoprofiling of serum-derived CBG to elucidate the Asn347-glycans and then used molecular dynamics simulations to study their impact on NE proteolysis. Importantly, we also identified O-glycosylation (di/sialyl T) across four RCL sites (Thr338/Thr342/Thr345/Ser350) of serum CBG close to the NE-targeted Val344–Thr345 cleavage site. A restricted N- and O-glycan co-occurrence pattern on the RCL involving exclusively Asn347 and Thr338 glycosylation was experimentally observed and supported in silico by modeling of a CBG–GalNAc-transferase (GalNAc-T) complex with various RCL glycans. GalNAc-T2 and GalNAc-T3 abundantly expressed by liver and gall bladder, respectively, showed in vitro a capacity to transfer GalNAc (Tn) to multiple RCL sites suggesting their involvement in RCL O-glycosylation. Recombinant CBG was then used to determine roles of RCL O-glycosylation through longitudinal NE-centric proteolysis experiments, which demonstrated that both sialoglycans (disialyl T) and asialoglycans (T) decorating Thr345 inhibit NE proteolysis. Synthetic RCL O-glycopeptides expanded on these findings by showing that Thr345-Tn and Thr342-Tn confer strong and moderate protection against NE cleavage, respectively. Molecular dynamics substantiated that short Thr345-linked O-glycans abrogate NE interactions. In conclusion, we report on biologically relevant CBG RCL glycosylation events, which improve our understanding of mechanisms governing cortisol delivery to inflamed tissues.

Publications:

Tags:

Proteoglycans

Related Projects:

No related projects available


Files:

File Name File Description File Type File Size File URL
Supporting information Supporting Figures S1–S20. Supporting Tables S1–S5. Supporting File S1. In-house bash script used for molecular modelling of CBG (zipped). zip 3.33 MB Login to download